GlassScriptPhysician profile
Robert G Anderson
NPI 1326064270
$75,002.81
in general payments reported to CMS, 2019-2025
18 companies · $9,188 in 2025
The $9,188 reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $279 · 2021: $4,615 · 2022: $26K · 2023: $15K · 2024: $19K · 2025: $9,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Food and Beverage: $1,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,627.54 |
| Food and Beverage | $1,886.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41,175.85 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $33,080.29 | 2019-2023 | |
| Davol INC. | $150.89 | 2025 | |
| Sientra, INC. | $139.70 | 2019 | |
| Integra Lifesciences Corporation | $81.74 | 2024-2025 | Integra, Surgimend, Omnigraft |
| Pylant Medical | $81.05 | 2021-2024 | |
| Merz North America, INC. | $38.43 | 2020 | |
| Mimedx Group, INC. | $30.97 | 2024 | |
| Mentor Worldwide LLC | $28.06 | 2019 | |
| Tepha INC | $27.97 | 2019 | |
| Acera Surgical, INC. | $27.95 | 2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $25.39 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $23.11 | 2019 | |
| Baxter Healthcare | $21.90 | 2024 | Artiss |
| Smith+Nephew, INC. | $18.83 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $18.31 | 2019 | |
| Kerecis Limited | $17.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $15.32 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.